Group 1 - The core point of the article is that Kexing Pharmaceutical-B has been actively repurchasing its shares, indicating a potential confidence in its stock value and future performance [2][3] - On November 7, the company repurchased 876,500 shares at a price range of HKD 15.180 to HKD 16.000, totaling HKD 13.7793 million [2] - The stock closed at HKD 15.790 on the same day, reflecting a 0.70% increase, with a total trading volume of HKD 35.7076 million [2] Group 2 - Since November 6, the company has conducted share buybacks for two consecutive days, totaling 2.6105 million shares and an aggregate amount of HKD 40.0871 million [2] - The stock has experienced a cumulative increase of 1.02% during this buyback period [2] - Year-to-date, the company has completed four buyback transactions, repurchasing a total of 3.0655 million shares for a total amount of HKD 47.7551 million [3]
科济药业-B(02171.HK)连续2日回购，累计回购261.05万股